Updates are available Correction dated 2019-08-22
Click to view Correction: https://doi.org/10.1038/s41589-019-0363-x
-
Authors
Hetz, Claudio https://orcid.org/0000-0001-7724-1767
Axten, Jeffrey M. https://orcid.org/0000-0002-8999-3381
Patterson, John B. https://orcid.org/0000-0002-2871-2945
- License Information
-
More Information
Article History
Received: 2 November 2018
Accepted: 17 June 2019
First Online: 18 July 2019
Change Date: 22 August 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: J.M.A. is an employee and stockholder of GlaxoSmithKline, and a named inventor of PERK inhibitor patents owned by GlaxoSmithKline. J.B.P. is and employee and stockholder of Orinove, Inc. and a named inventor of IRE1 inhibitor patents owned by Orinove, Inc.
